Prognostic implications of neutrophil ‐to‐lymphocyte ratio in patients with extensive‐stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real‐world study
ConclusionNLRT2 and irAEs can predict the prognosis of ES-SCLC patients with first-line ES-SCLC receiving PD-L1 inhibitors combined with chemotherapy.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Huanhuan Bi,
Dunqiang Ren,
Yuting Xiao,
Yinxue Zhou,
Bingqian Yi,
Weizhong Han,
Yanmei Shao,
Jingluan Wang,
Chunling Zhang,
Hongmei Wang Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Small Cell Lung Cancer | Statistics | Study